Q32 Bio Inc Earnings

The next earnings date for Q32 Bio Inc has not yet been scheduled.

Analyst Estimates of Q32 Bio Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Q32 Bio Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/07/2025	Before Market	$-0.90	26.83%
03/11/2025	Before Market	$-1.16	24.18%
11/12/2024	Before Market	$-1.46	-4.07%
08/08/2024	Before Market	$-1.42	-36.54%
05/09/2024	Before Market	$-14.95	-544.40%
03/13/2024	Before Market	$-0.28	6.67%
11/15/2023	---	$-10.26	-35.71%
08/15/2023	---	$-10.91	---
05/12/2023	---	$-9.00	---
03/10/2023	---	$-10.74	---
11/11/2022	---	$-10.57	---
08/16/2022	---	$-9.12	---
05/17/2022	---	$28.65	---
03/24/2022	---	$-10.58	---
11/15/2021	---	$-9.65	---
08/13/2021	---	$-9.72	---
05/07/2021	---	$-0.38	---
03/12/2021	---	$-11.15	---
11/10/2020	---	$-11.24	---
08/11/2020	---	$-14.07	---
05/08/2020	---	$-14.09	---
03/13/2020	---	$-9.87	---
11/13/2019	---	$-12.15	---
08/09/2019	---	$-10.98	---
05/14/2019	---	$-11.48	---
03/12/2019	---	$-9.16	---
11/14/2018	---	$-7.15	---
08/14/2018	---	$-6.30	---
05/14/2018	---	$-5.06	---

More About Q32 Bio Inc

Website

https://www.q32bio.com

Country

USA

Full Time Employees

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.

“Q32 Bio Inc Earnings” Can Refer to the Q32 Bio Inc Earnings Date

Some people say “Q32 Bio Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Q32 Bio Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Q32 Bio Inc Stock on the Earnings Date

If you own Q32 Bio Inc stock (QTTB) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Q32 Bio Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Q32 Bio Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Q32 Bio Inc Earnings

You can contact us any time if you would like to ask questions about Q32 Bio Inc earnings or anything else related to the stock market.